NAUT · XBRL financial data

Nautilus Biotechnology financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (NAUT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Research and development	12,432	29,352	37,672	47,251	50,477	41,110
General and administrative	3,312	21,146	25,946	28,901	30,999	25,727
Total operating expenses	15,744	50,498	63,618	76,152	81,476	66,837
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	(15,619)	(50,315)	(57,924)	(63,675)	(70,780)	(59,001)
Earnings per share, basic USD per share	(0.54)	(0.60)	(0.46)	(0.51)	(0.56)	(0.47)
Earnings per share, diluted USD per share	(0.54)	(0.60)	(0.46)	(0.51)	(0.56)	(0.47)
Weighted average shares, basic thousands of shares	29,090	84,464	124,590	124,919	125,427	126,257
Weighted average shares, diluted thousands of shares	29,090	84,464	124,590	124,919	125,427	126,257

Fiscal years (NAUT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	36,607	185,619	114,523	19,397	27,646	12,388
Marketable securities	40,135	160,110	69,948	154,021	102,247	91,018
Marketable securities, non-current	—	—	129,169	90,647	76,405	52,739
Prepaid and other current assets	917	3,493	2,738	3,419	2,933	2,557
Total current assets	1,305	349,222	187,209	176,837	132,826	105,963
Property and equipment, net	1,371	2,483	3,700	4,267	4,076	3,457
Right-of-use asset	4,842	29,377	28,866	32,634	28,256	27,773
Total assets	150,858	398,450	350,052	305,565	242,743	191,112
Accounts payable	470	1,723	1,272	1,639	987	943
Accrued liabilities	389	—	—	—	—	—
Total current liabilities	389	5,812	6,791	9,122	7,632	7,952
Lease liability, non-current	3,296	29,062	28,337	31,090	26,381	26,187
Total liabilities	5,621	34,874	35,128	40,212	34,013	34,139
Accumulated deficit	(523)	(80,640)	(138,564)	(202,239)	(273,019)	(332,020)
Total stockholders' equity	5,000	363,576	314,924	265,353	208,730	156,973
Total liabilities and equity	150,858	398,450	350,052	305,565	242,743	191,112
Common shares outstanding (cover page) thousands of shares	33,070	124,426	124,866	125,098	126,148	126,564

Fiscal years (NAUT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(15,619)	(50,315)	(57,924)	(63,675)	(70,780)	(59,001)
Stock-based compensation	369	7,934	10,380	12,137	12,701	6,844
Net cash from operating activities	(13,996)	(39,241)	(45,806)	(51,711)	(59,145)	(50,696)
Purchases of property and equipment	921	2,269	2,324	2,442	2,122	1,277
Net cash from investing activities	(25,279)	(138,964)	(25,740)	(43,735)	66,250	35,224
Net cash from financing activities	75,899	327,447	562	368	1,144	214
Net change in cash	36,624	149,242	(70,984)	(95,078)	8,249	(15,258)

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Nautilus Biotechnology	10,467	234	(13,281)*	127.4M	6.1 quarters	Q3 FY26 10-QSep 30, 2026
Sypris Solutions	not reported	30,341	1,863*	23.0M	—	Q2 FY26 10-QJul 5, 2026
ClearSign Technologies	9,889	not reported	(1,236)*	6.8M	8.0 quarters	Q2 FY26 10-QJun 30, 2026
Data I/O	10,843	5,149	(2,939)*	10.4M	3.7 quarters	Q2 FY26 10-QJun 30, 2026
Optex Systems Holdings	6,175	9,729	2,323*	7.0M	—	Q3 FY26 10-QJun 28, 2026
Birchtech	11,836	3,791	(2,790)*	26.3M	4.2 quarters	Q2 FY26 10-QJun 30, 2026
ScanTech AI Systems	158	631	(758)*	75.6M	0.2 quarters	Q3 FY25 10-QSep 30, 2025
MultiSensor AI Holdings	21,005	1,695	(2,392)*	2.2M	8.8 quarters	Q2 FY26 10-QJun 30, 2026
Kewaunee Scientific	8,246	66,320	1,976	2.9M	—	Q1 FY27 10-QJul 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.